Capricor Therapeutics annual net debt
2020
2021
2022
2023
2024
2025
Capricor Therapeutics Net Debt Growth & History (CAPR)
Capricor Therapeutics's net debt was −$273.3M for fiscal 2025.
View full Capricor Therapeutics company overviewCapricor Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$273.3M | −$263.5M | — |
| 2024 | 2024-12-31 | −$9.8M | $2.6M | — |
| 2023 | 2023-12-31 | −$12.5M | −$5.1M | — |
| 2022 | 2022-12-31 | −$7.4M | $24.6M | — |
| 2021 | 2021-12-31 | −$32.0M | $650,939 | — |
| 2020 | 2020-12-31 | −$32.7M | — | — |
Capricor Therapeutics quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $70.1M | $92.3M | — |
| Q1 2026 | 2026-03-31 | −$90.6M | −$63.1M | — |
| Q4 2025 | 2025-12-31 | −$273.3M | −$263.5M | — |
| Q3 2025 | 2025-09-30 | −$5.0M | $61.8M | — |
| Q2 2025 | 2025-06-30 | −$22.2M | −$13.3M | — |
| Q1 2025 | 2025-03-31 | −$27.5M | −$23.4M | — |
| Q4 2024 | 2024-12-31 | −$9.8M | $2.6M | — |
| Q3 2024 | 2024-09-30 | −$66.7M | −$60.2M | — |
| Q2 2024 | 2024-06-30 | −$8.9M | −$1.2M | — |
| Q1 2024 | 2024-03-31 | −$4.2M | $4.0M | — |
| Q4 2023 | 2023-12-31 | −$12.5M | −$5.1M | — |
| Q3 2023 | 2023-09-30 | −$6.6M | −$938,201 | — |
| Q2 2023 | 2023-06-30 | −$7.6M | $6.0M | — |
| Q1 2023 | 2023-03-31 | −$8.2M | $47.3M | — |
| Q4 2022 | 2022-12-31 | −$7.4M | $24.6M | — |
| Q3 2022 | 2022-09-30 | −$5.6M | $35.2M | — |
| Q2 2022 | 2022-06-30 | −$13.7M | $24.4M | — |
| Q1 2022 | 2022-03-31 | −$55.5M | −$13.6M | — |
| Q4 2021 | 2021-12-31 | −$32.0M | $650,939 | — |
| Q3 2021 | 2021-09-30 | −$40.8M | — | — |
| Q2 2021 | 2021-06-30 | −$38.1M | — | — |
| Q1 2021 | 2021-03-31 | −$41.9M | — | — |
| Q4 2020 | 2020-12-31 | −$32.7M | — | — |
Capricor Therapeutics net debt trends
Over the last five fiscal years, Capricor Therapeutics's net debt decreased from −$32.7M to −$273.3M, a change of −$240.7M. The latest reported quarter, Q2 2026, shows $70.1M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Capricor Therapeutics source filings ↗